From major journals, first or last author from the Institute for Cancer Research
Nissen-Meyer J, Skotland T, Boye E(2022) Are doping tests in sports trustworthy? : Athletes suffer from insufficiently defined criteria for doping tests EMBO Rep, 23(3), EMBR202154431 DOI 10.15252/embr.202154431, PubMed 39443692
Egeland EV, Seip K, Skourti E, Øy GF, Pettersen SJ, Pandya AD, Dahle MA, Haugen MH, Kristian A, Nakken S, Engebraaten O, Mælandsmo GM, Prasmickaite L(2024) The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy Br J Cancer(in press) DOI 10.1038/s41416-024-02875-5, PubMed 39390250
Møller P, Seppälä TT, Dominguez-Valentin M, Sampson J(2024) Commentary on Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank J Med Genet(in press) DOI 10.1136/jmg-2024-110385, PubMed 39375027
Palacios D, Majhi RK, Szabo EK, Clement D, Lachota M, Netskar H, Penna L, Krokeide SZ, Vincenti M, Kveberg L, Malmberg KJ(2024) The G Protein-Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration J Immunol, 213(9), 1349-1357 DOI 10.4049/jimmunol.2400228, PubMed 39320215
Escribá R, Beksac M, Bennaceur-Griscelli A, Glover JC, Koskela S, Latsoudis H, Querol S, Alvarez-Palomo B(2024) Correction: Current Landscape of iPSC Haplobanks Stem Cell Rev Rep(in press) DOI 10.1007/s12015-024-10804-5, PubMed 39422809
Møller P, Seppälä TT, Dominguez-Valentin M, Sampson J(2024) Commentary on Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank J Med Genet(in press) DOI 10.1136/jmg-2024-110385, PubMed 39375027